Sugi Predict

Sugi Predict / Compounds / SCHEMBL3496258

SCHEMBL3496258

SCHEMBL3496258

COCCN1C(=O)COc2cc(-c3ccccc3Nc3ncc(F)c(NC4CC(C)(C)N(C)C(C)(C)C4)n3)cnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCQ Q04759 2/20 0.41
▸ AURKA O14965 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ INSR P06213 3/20 0.35
▸ MET P08581 2/20 0.35
▸ MAP4K1 Q92918 1/20 0.35
▸ EGFR P00533 2/20 0.35
▸ CCNT1 O60563 2/20 0.34
▸ CDK9 P50750 2/20 0.34
▸ GSK3A P49840 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ MAPK15 Q8TD08 1/20 0.33
▸ CAMKK2 Q96RR4 1/20 0.33
▸ RET P07949 1/20 0.33
▸ KIF5B P33176 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ ETV6 P41212 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ CCDC6 Q16204 1/20 0.33
▸ BTK Q06187 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3496148 0.91 PRKCQ (0.41) PRKCQAURKAAURKBINSRMET
SCHEMBL3494264 0.90 LRRK2 (0.36) PRKCQEGFRLRRK2RETKIF5B
SCHEMBL3495361 0.90 SYK (0.45) MAP4K1SYK
SCHEMBL3496415 0.89 PRKCQ (0.41) PRKCQAURKAAURKBINSRMET
SCHEMBL3495846 0.83 INSR (0.36) PRKCQAURKAAURKBINSRMET
SCHEMBL3497184 0.83 SYK (0.45) MAP4K1SYK
SCHEMBL3497757 0.82 PRKCQ (0.40) PRKCQAURKAAURKBINSRMAP4K1
SCHEMBL3495091 0.82 FLT3 (0.39) PRKCQAURKAAURKBINSRMET
SCHEMBL3495366 0.81 CSNK2A2 (0.35) INSRMETEGFRLRRK2RET
SCHEMBL3493831 0.81 SYK (0.45) MAP4K1RETKIF5BKDRETV6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. 2010-05-27 — — US claimed
EP-2183225-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2010-05-12 — — EP claimed
WO-2009012421-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2009-01-22 — — WO claimed
US-8993585-B2 Cyclic amine substituted pyrimidinediamines as PKC inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2015-03-31 — — US disclosed
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. 2010-05-27 — — US disclosed
EP-2183225-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2010-05-12 — — EP disclosed
WO-2009012421-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2009-01-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS PRKCH, PKD2, PRKCQ PRKCQ 3/4885AURKA 495/4885AURKB 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.